Thiazolidinedione derivatives, preparation thereof and use thereof in cancer treatment

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9522909
APP PUB NO 20140364465A1
SERIAL NO

14374030

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to thiazolidinedione derivatives, to the processes for preparing same and to the therapeutic use thereof for preventing or treating cancer, and more specifically breast cancer. These compounds are of formula (I) and exhibit, at a concentration of 100 μM, a hepatocyte viability preferably greater than 60%, preferably greater than 80% and more preferentially greater than 85%.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS3 RUE MICHEL ANGE PARIS CEDEX 16 75794
UNIVERSITE DE LORRAINE54052 NANCY CEDEX

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boisbrun, Michel Pulnoy, FR 1 0
Bordessa, Andrea Gravedona Ed Uniti, IT 1 0
Chapleur, Yves Nancy, FR 2 0
Flament, Stephane Vandoeuvre-les-nancy, FR 1 0
Grillier-Vuissoz, Isabelle Villiers-les-Nancy, FR 1 0
Kuntz, Sandra Crantenoy, FR 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 20, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00